GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Mannkind Corporation (MNKD) [hlAlert]

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such
as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.
( Total: 13 Current Stock Recommendations )
Mannkind Corporation   (13)
Sell 46% Hold 38% Buy 15%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Sell MNKD
down 80.30 %

Rating:
Sell MNKD
down 21.99 %

Rating:
Hold MNKD
up 57.55 %

Rating:
Hold MNKD
Mannkind Corporation (MNKD) rated Neutral by Piper Jaffray
Wednesday,  Nov 27, 2013  8:25 AM ET

Rating:
Sell MNKD
up 51.66 %

Rating:
Buy MNKD
up 57.55 %

Rating:
Hold MNKD

Rating:
Buy MNKD
down 18.54 %

Rating:
Buy MNKD
up 268.31 %
Mannkind Corporation (MNKD) rated Buy by BofA/Merrill
Monday,  Nov 5, 2012  8:25 AM ET

Rating:
Hold MNKD
Mannkind Corporation (MNKD) rated Neutral by JP Morgan
Friday,  Nov 2, 2012  8:25 AM ET

Rating:
Hold MNKD
Mannkind Corporation (MNKD) rated Neutral by Cowen & Co
Friday,  Apr 13, 2012  8:25 AM ET

Rating:
Buy MNKD
up 74.55 %

Rating:
Buy MNKD
up 34.82 %

Rating:
Hold MNKD

Rating:
Hold MNKD
down 48.30 %

Your Recent Stocks
SymbolLastChange
MNKD 0.77 down  -80.30 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy